Injectable Drug Delivery Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

  • Report Code : 591408
  • Pages : 130
  • Published On : Nov 2020
  • Industry : Medical Devices
  • Format :

Choose License Type

Single User License: US$ 2,800
Multi User License: US$ 5,600
Corporate User License: US$ 5,600
Summary

Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary
.
The global Injectable Drug Delivery market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for Injectable Drug Delivery are the significant development of demand and improvement of COVID-19 and geo-economics.

Based on the type of product, the global Injectable Drug Delivery market segmented into
Aesthetics
Antibiotics
Immunosuppressive Agents
Antihypertensive Agents

Based on the end-use, the global Injectable Drug Delivery market classified into
Aesthetics
Autoimmune Diseases
Hormonal Disorders
Infectious Diseases
Oncology
Pain Management

Based on geography, the global Injectable Drug Delivery market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]

And the major players included in the report are
Becton
Dickinson and Company
Baxter International
Gerresheimer
Pfizer
Schott
Sandoz
Teva Pharmaceutical Industries
Eli Lilly and Company
Antares Pharma
Eli Lilly & Company
Hospira
Novo Nordik
Sanofi
Terumo Corporation
Unilife Corporation
Zogenix
Scandinavian Health
Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL INJECTABLE DRUG DELIVERY INDUSTRY
2.1 Summary about Injectable Drug Delivery Industry
2.2 Injectable Drug Delivery Market Trends
2.2.1 Injectable Drug Delivery Production & Consumption Trends
2.2.2 Injectable Drug Delivery Demand Structure Trends
2.3 Injectable Drug Delivery Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Analgesics
4.2.2 Antibiotics
4.2.3 Immunosuppressive Agents
4.2.4 Antihypertensive Agents
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Aesthetics
4.3.2 Autoimmune Diseases
4.3.3 Hormonal Disorders
4.3.4 Infectious Diseases
4.3.5 Oncology
4.3.6 Pain Management
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Analgesics
5.2.2 Antibiotics
5.2.3 Immunosuppressive Agents
5.2.4 Antihypertensive Agents
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Aesthetics
5.3.2 Autoimmune Diseases
5.3.3 Hormonal Disorders
5.3.4 Infectious Diseases
5.3.5 Oncology
5.3.6 Pain Management
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Analgesics
6.2.2 Antibiotics
6.2.3 Immunosuppressive Agents
6.2.4 Antihypertensive Agents
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Aesthetics
6.3.2 Autoimmune Diseases
6.3.3 Hormonal Disorders
6.3.4 Infectious Diseases
6.3.5 Oncology
6.3.6 Pain Management
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Analgesics
7.2.2 Antibiotics
7.2.3 Immunosuppressive Agents
7.2.4 Antihypertensive Agents
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Aesthetics
7.3.2 Autoimmune Diseases
7.3.3 Hormonal Disorders
7.3.4 Infectious Diseases
7.3.5 Oncology
7.3.6 Pain Management
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Analgesics
8.2.2 Antibiotics
8.2.3 Immunosuppressive Agents
8.2.4 Antihypertensive Agents
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Aesthetics
8.3.2 Autoimmune Diseases
8.3.3 Hormonal Disorders
8.3.4 Infectious Diseases
8.3.5 Oncology
8.3.6 Pain Management
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Analgesics
9.2.2 Antibiotics
9.2.3 Immunosuppressive Agents
9.2.4 Antihypertensive Agents
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Aesthetics
9.3.2 Autoimmune Diseases
9.3.3 Hormonal Disorders
9.3.4 Infectious Diseases
9.3.5 Oncology
9.3.6 Pain Management
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Becton
10.1.2 Dickinson and Company
10.1.3 Baxter International
10.1.4 Gerresheimer
10.1.5 Pfizer
10.1.6 Schott
10.1.7 Sandoz
10.1.8 Teva Pharmaceutical Industries
10.1.9 Eli Lilly and Company
10.1.10 Antares Pharma
10.1.11 Eli Lilly & Company
10.1.12 Hospira
10.1.13 Novo Nordik
10.1.14 Sanofi
10.1.15 Terumo Corporation
10.1.16 Unilife Corporation
10.1.17 Zogenix
10.1.18 Scandinavian Health
10.2 Injectable Drug Delivery Sales Date of Major Players (2017-2020e)
10.2.1 Becton
10.2.2 Dickinson and Company
10.2.3 Baxter International
10.2.4 Gerresheimer
10.2.5 Pfizer
10.2.6 Schott
10.2.7 Sandoz
10.2.8 Teva Pharmaceutical Industries
10.2.9 Eli Lilly and Company
10.2.10 Antares Pharma
10.2.11 Eli Lilly & Company
10.2.12 Hospira
10.2.13 Novo Nordik
10.2.14 Sanofi
10.2.15 Terumo Corporation
10.2.16 Unilife Corporation
10.2.17 Zogenix
10.2.18 Scandinavian Health
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT


List of Table
1.Table Injectable Drug Delivery Product Type Overview
2.Table Injectable Drug Delivery Product Type Market Share List
3.Table Injectable Drug Delivery Product Type of Major Players
4.Table Brief Introduction of Becton
5.Table Brief Introduction of Dickinson and Company
6.Table Brief Introduction of Baxter International
7.Table Brief Introduction of Gerresheimer
8.Table Brief Introduction of Pfizer
9.Table Brief Introduction of Schott
10.Table Brief Introduction of Sandoz
11.Table Brief Introduction of Teva Pharmaceutical Industries
12.Table Brief Introduction of Eli Lilly and Company
13.Table Brief Introduction of Antares Pharma
14.Table Brief Introduction of Eli Lilly & Company
15.Table Brief Introduction of Hospira
16.Table Brief Introduction of Novo Nordik
17.Table Brief Introduction of Sanofi
18.Table Brief Introduction of Terumo Corporation
19.Table Brief Introduction of Unilife Corporation
20.Table Brief Introduction of Zogenix
21.Table Brief Introduction of Scandinavian Health
22.Table Products & Services of Becton
23.Table Products & Services of Dickinson and Company
24.Table Products & Services of Baxter International
25.Table Products & Services of Gerresheimer
26.Table Products & Services of Pfizer
27.Table Products & Services of Schott
28.Table Products & Services of Sandoz
29.Table Products & Services of Teva Pharmaceutical Industries
30.Table Products & Services of Eli Lilly and Company
31.Table Products & Services of Antares Pharma
32.Table Products & Services of Eli Lilly & Company
33.Table Products & Services of Hospira
34.Table Products & Services of Novo Nordik
35.Table Products & Services of Sanofi
36.Table Products & Services of Terumo Corporation
37.Table Products & Services of Unilife Corporation
38.Table Products & Services of Zogenix
39.Table Products & Services of Scandinavian Health
40.Table Market Distribution of Major Players
41.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
42.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
43.Table Global Injectable Drug Delivery Market Forecast (Million USD) by Region 2021f-2026f
44.Table Global Injectable Drug Delivery Market Forecast (Million USD) Share by Region 2021f-2026f
45.Table Global Injectable Drug Delivery Market Forecast (Million USD) by Demand 2021f-2026f
46.Table Global Injectable Drug Delivery Market Forecast (Million USD) Share by Demand 2021f-2026f

List of Figure
1.Figure Global Injectable Drug Delivery Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
2.Figure Global Injectable Drug Delivery Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
3.Figure Global Injectable Drug Delivery Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
4.Figure Global Injectable Drug Delivery Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
5.Figure Global Injectable Drug Delivery Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
6.Figure Global Injectable Drug Delivery Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
7.Figure Global Injectable Drug Delivery Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
8.Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
9.Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
10.Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
11.Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
12.Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
13.Figure Analgesics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
14.Figure Antibiotics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
15.Figure Immunosuppressive Agents Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
16.Figure Antihypertensive Agents Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
17.Figure Aesthetics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
18.Figure Autoimmune Diseases Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
19.Figure Hormonal Disorders Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
20.Figure Infectious Diseases Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
21.Figure Oncology Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
22.Figure Pain Management Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
23.Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
24.Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
25.Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
26.Figure Analgesics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
27.Figure Antibiotics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
28.Figure Immunosuppressive Agents Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
29.Figure Antihypertensive Agents Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
30.Figure Aesthetics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
31.Figure Autoimmune Diseases Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
32.Figure Hormonal Disorders Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
33.Figure Infectious Diseases Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
34.Figure Oncology Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
35.Figure Pain Management Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
36.Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
37.Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
38.Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
39.Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
40.Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
41.Figure Analgesics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
42.Figure Antibiotics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
43.Figure Immunosuppressive Agents Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
44.Figure Antihypertensive Agents Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
45.Figure Aesthetics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
46.Figure Autoimmune Diseases Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
47.Figure Hormonal Disorders Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
48.Figure Infectious Diseases Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
49.Figure Oncology Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
50.Figure Pain Management Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
51.Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
52.Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
53.Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
54.Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
55.Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
56.Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
57.Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
58.Figure Analgesics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
59.Figure Antibiotics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
60.Figure Immunosuppressive Agents Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
61.Figure Antihypertensive Agents Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
62.Figure Aesthetics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
63.Figure Autoimmune Diseases Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
64.Figure Hormonal Disorders Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
65.Figure Infectious Diseases Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
66.Figure Oncology Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
67.Figure Pain Management Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
68.Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
69.Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
70.Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
71.Figure Analgesics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
72.Figure Antibiotics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
73.Figure Immunosuppressive Agents Segmen

Last-Mile Delivery Logistics Platform Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)...

The Last-Mile Delivery Logistics Platform Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscap...

Last-Mile Drone Delivery Service Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)...

The Last-Mile Drone Delivery Service Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, ma...

Fresh Pet Food Delivery Service Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)...

The Fresh Pet Food Delivery Service Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, man...

Fresh Cat Food Delivery Service Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)...

The Fresh Cat Food Delivery Service Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, man...

Drug Temperature Monitoring System Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)...

The Drug Temperature Monitoring System Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, ...

Small Molecule Drug CDMO Services Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)...

The Small Molecule Drug CDMO Services Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, m...

Data Delivery Services Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)...

The Data Delivery Services Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufacturer...

Global Immune Thrombocytopenia Drug Market (2024 Edition): Analysis By Treatment (Intravenous Immunoglobulins, Thrombopoietin Receptor Agonists, Corticosteroids, Others), By Type, By End-User, By Region: Market Insights and Forecast (2019-2029)...

Executive Summary Azoth Analytics has released a research report titled "Global Immune Thrombocytopenia Drug Market (2024 Edition)" which provides a complete analysis of the Global Immune Thrombocytopenia Drug industry in terms of market segmentation By Treatment (Intravenous Immunoglob...

Global Irritable Bowel Disease Market (2024 Edition): Analysis By Drug Class (Corticosteroids, JAK inhibitors, TNF inhibitors, Other Drug Classes), By Route of Administration, By Indication, By Region, By Country: Market Insights and Forecast (2019-2029)...

Executive Summary Azoth Analytics has released a research report titled "Global Irritable Bowel Disease Market (2024 Edition)" which provides a complete analysis of the Global Irritable Bowel Disease industry in terms of market segmentation By Drug Class (Corticosteroids, JAK inhibitors...

Intelligent Drug Delivery Technology Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)...

The Intelligent Drug Delivery Technology Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape...